Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The dose will be decreased.
B The medication will be stopped.
C The dose will be increased.
D The dose will be unchanged.
Question #2
A Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B Not a candidate for fondaparinux based on an insufficient creatinine clearance
C Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
D Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
Question #3
A Too high
B Too low
C Within normal limits
D Inadequate to evaluate treatment
Question #4
A Within normal limits
B Significantly decreased
C Inadequate to evaluate treatment
D Significantly elevated
Question #5
A Assess for dysrhythmias.
B Administer prescribed vitamin K if bruising is observed.
C Stop the medication if the systolic blood pressure drops below 110 mm Hg.
D Monitor liver enzymes.
Question #6
A Administering the medication intramuscularly in the vastus lateralis
B Checking if the patient’s prescription contains enoxaparin
C Massaging the site after the injection
D Administering the medication when convenient
Question #7
A “I refrain from drinking coffee and citrus fruit juices daily.”
B “I take ginkgo supplements for memory enhancement.”
C “I eat 1 cup of green leafy vegetables daily.”
D “I do not take aspirin for pain relief.”
Question #8
A “I avoid tight-fitting stockings or leggings.”
B “I get up and walk around at least once an hour.”
C “I’ve been on prolonged bed rest.”
D “I never sit with my legs crossed at the knees.”
Question #9
A Alteplase
B Phytonadione
C Aminocaproic acid
D Tranexamic acid
Question #10
A Cimetidine
B Barbiturate
C Carbamazepine
D Cholestyramine
Question #11
A Platelet count, Heart rate, Blood pressure
B Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
C Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
D Heart rate, Hemoglobin, Blood pressure
Question #12
A “I will store the bottle in a dry place.”
B “I will take the medication with food.”
C “I will use the medication within 60 days after it is opened.”
D “I will place the pills in an organizer for easy use.”
Question #13
A Platelet count of 80,000/mm3
B Diagnosis of diabetes mellitus
C Creatinine clearance of 25 mL/min
D Loss of 10 pounds
Question #14
A The dosage of the amiodarone will be decreased by half.
B The dosage of the amiodarone will be increased by half.
C The dosage of the warfarin will be increased by half.
D The dosage of the warfarin will be decreased by half.
Question #15
A Monitor the patient for decreased action of the anticoagulant.
B Monitor the patient for increased action of the anticoagulant.
C Instruct the patient to notify the nurse if he or she begins to experience discomfort.
D Continue to administer cimetidine with each dose of warfarin.
Question #16
A Local thrombosis from a peripheral intravenous line
B Severe chest pain for the past 2 hours
C Gastrointestinal bleed
D Peptic ulcer disease
Question #17
A Monitor the patient and check the therapeutic range.
B Notify the health care provider immediately.
C Increase the dose of heparin.
D Stop the medication.
Question #18
A Outside the expected target therapeutic level of anticoagulation; it is too high
B Within the expected target therapeutic level of anticoagulation
C Outside the expected target therapeutic level of anticoagulation; it is too low
D Cannot be interpreted without knowing the prothrombin time and international normalized ratio
Question #19
A Platelet count: 100,000/mm3
B Prothrombin time: 13 sec
C Hemoglobin level: 11 g/dL
D Leukocyte count: 3000 cells/mm3
Question #20
A Atrial fibrillation, History of myocardial infarction
B History of myocardial infarction, Chronic obstructive pulmonary disease
C Peptic ulcer disease, Chronic kidney disease
D Chronic obstructive pulmonary disease, Atrial fibrillation
Question #21
A Platelet count of 95,000/mm3
B Potassium level of 3.5 mEq/L
C Activated partial thromboplastin time (aPTT) of 37 seconds
D International normalized ratio (INR) of 1
Question #22
A Outside the expected target therapeutic level of anticoagulation; it is too low
B Outside the expected target therapeutic level of anticoagulation; it is too high
C The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
D Within the expected target therapeutic level of anticoagulation
Question #23
A “Discard the drug within 21 days of opening the original container.”
B “Store the drug with the desiccant-drying agent in the packing cap.”
C “Remove from the original package and place in aluminum foil.”
D “Refrigerate and keep away from direct sunlight.”
Question #24
A Ketoconazole
B Amiodarone
C Furosemide
D Enoxaparin
Question #25
A Monitor the patient’s laboratory values correctly.
B Teach the patient about dietary restrictions while on the medication.
C Have protamine sulfate readily available at all times.
D Ensure that a loading dose was initially administered when beginning
Question #26
A Administer protamine sulfate IV.
B Wait for the INR to decrease.
C Administer vitamin K1 (phytonadione) IV.
D Stop the intravenous (IV) drip.
Question #27
A Prevention of new clots from forming
B Dissolution of the clot that caused the heart attack
C A quick decrease in pain
D Reversal of damage from the infarction
Question #28
A “I should follow a low-cholesterol diet during the therapy.”
B “I should take oral contraceptives during the therapy.”
C “I should refrain from eating broccoli during the therapy.”
D “I should not use any acetaminophen during the therapy.”
Question #29
A “I should keep taking ibuprofen for my arthritis.”
B “I will double my dose if I forget to take it the day before.”
C “I should decrease the dose if I start bruising easily.”
D “I should use a soft toothbrush for dental hygiene.”
Question #30
A “There is no real difference; dalteparin is interchangeable with regular heparin.”
B “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
C “The only difference is that regular heparin dosing is based on the patient’s weight.”
D “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
Question #31
A Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
B Rub the administration site after injecting.
C Utilize the Z-track method to inject the medication.
D Administer the medication into subcutaneous tissue of the abdomen.
Question #32
A “I will contact my health care provider if I develop excessive bruising.”
B “I will take my medication at the same time each day.”
C “I will increase dark green leafy vegetables in my diet.”
D “I will avoid contact sports.”
Question #33
A Calcium gluconate
B Vitamin K
C Protamine sulfate
D Vitamin E
Question #34
A Vitamin K daily
B Warfarin daily
C Recombinant factors
D Aspirin daily (i.e., 81 mg)
Question #35
A Peripheral vascular disease
B Vitamin K deficiency
C Acute unstable angina
D Transient ischemic attack
Question #36
A Heparin subcutaneously
B Warfarin orally
C Enoxaparin intramuscularly
D Dabigatran orally
Question #37
A Ingestion of acetaminophen
B Over-the-counter medications
C Platelet level
D Urine culture
Question #38
A July 31
B September 15
C October 1
D August 29
Question #39
A Chest pain
B Edema
C Itching
D Nausea
Question #40
A Blood urea nitrogen (BUN) level of 12 mg/dL
B International normalized ratio (INR) of 1.0
C Activated partial thromboplastin time (aPTT) of 120 seconds
D Platelet count of 150,000 mm3
Question #41
A Hemoglobin level of 16.5 g/dL
B Creatinine clearance value of 40 mL/min
C Fasting blood glucose level of 95 mg/dL
D Platelet count of 75,000 cell/μL
Question #42
A Antithrombin III
B Vitamin K
C Thrombin
D Factor Xa
Question #43
A Tranexamic acid
B Alteplase
C Desmopressin
D Aminocaproic acid
Question #44
A Antifibrinolytic
B Antiplatelet
C Thrombolytic
D Anticoagulant
Question #45
A Coronary artery disease
B Heart failure
C Cardiomyopathy
D Acute myocardial infarction
Question #46
A Aspirin
B Cilostazol
C Pentoxifylline
D Dipyridamole
Question #47
A Fondaparinux
B Argatroban
C Dabigatran
D Enoxaparin
Question #48
A Selective factor Xa inhibitors
B Direct thrombin inhibitors
C Heparins
D Warfarin
Question #49
A Anticoagulants dissolve clots.
B Anticoagulants alter platelet function.
C Anticoagulants interfere with drug metabolism.
D Anticoagulants prevent clots from forming.
Question #50
A Thrombolytic
B Anticoagulant
C Antiplatelet
D Antifibrinolytic
Question #51
A Embolus to the lungs
B Medication reaction
C Anxiety
D Fatigue from walking with pain
Question #52
A Increasing the dose of enoxaparin
B Administering vitamin K1
C Infusing 50 mL of warfarin sodium
D Administering protamine sulfate
Question #53
A Aspirin
B Calcium
C Potassium
D Vitamin K